Variant report
Variant | nsv598413 |
---|---|
Chromosome Location | chr5:68306058-68320702 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:15)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:15 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:68303714..68306430-chr5:68307322..68309194,2 | MCF-7 | breast: | |
2 | chr5:68311729..68314599-chr5:68315018..68317996,2 | K562 | blood: | |
3 | chr5:68319742..68320506-chr5:68379422..68380332,4 | MCF-7 | breast: | |
4 | chr5:68312049..68313667-chr5:68319112..68320759,2 | K562 | blood: | |
5 | chr5:68314784..68316658-chr5:68339254..68342073,2 | K562 | blood: | |
6 | chr5:68312049..68314191-chr5:68317998..68320759,3 | K562 | blood: | |
7 | chr5:68312049..68313667-chr5:68319112..68320759,2 | K562 | blood: | |
8 | chr5:68311729..68314599-chr5:68315018..68317996,2 | K562 | blood: | |
9 | chr14:47749473..47749973-chr5:68319722..68320581,2 | MCF-7 | breast: | |
10 | chr5:68303714..68306430-chr5:68307322..68309194,2 | MCF-7 | breast: | |
11 | chr5:68319293..68321703-chr5:68323264..68324934,2 | K562 | blood: | |
12 | chr5:68319705..68320603-chr5:68630318..68631248,3 | K562 | blood: | |
13 | chr5:68312049..68314191-chr5:68317998..68320759,3 | K562 | blood: | |
14 | chr5:68319643..68320584-chr5:68379379..68380063,3 | K562 | blood: | |
15 | chr5:68320167..68322088-chr5:68342197..68344022,2 | K562 | blood: |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-CCDC125-13 | chr5:68320037-68320857 | NONHSAT101881 |
2 | lnc-CCDC125-13 | chr5:68309537-68309757 | NONHSAT101881 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000250237 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs12187051 | chr5:68306058-68306059 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs562306758 | chr5:68306067-68306068 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs529529428 | chr5:68306070-68306071 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs368874623 | chr5:68306133-68306134 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs566040875 | chr5:68306146-68306147 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs539777664 | chr5:68306170-68306171 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs199568236 | chr5:68306224-68306225 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs377728946 | chr5:68306228-68306229 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs190708324 | chr5:68306250-68306251 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs373111988 | chr5:68306283-68306284 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs374272733 | chr5:68306308-68306309 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs374888038 | chr5:68306309-68306310 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs555923915 | chr5:68306340-68306341 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs567886554 | chr5:68306378-68306379 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs553687052 | chr5:68306413-68306414 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs146438752 | chr5:68306442-68306443 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs572087088 | chr5:68306484-68306485 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs545783513 | chr5:68306486-68306487 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs139814514 | chr5:68306516-68306517 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs557816289 | chr5:68306523-68306524 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs78470421 | chr5:68306539-68306540 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs368774347 | chr5:68306550-68306551 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs544097010 | chr5:68306589-68306590 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs562387488 | chr5:68306623-68306624 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs115770950 | chr5:68306627-68306628 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs541272714 | chr5:68306630-68306631 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs559785373 | chr5:68306654-68306655 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs181567661 | chr5:68306660-68306661 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs6861898 | chr5:68306669-68306670 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs6880936 | chr5:68306670-68306671 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs148936931 | chr5:68306671-68306672 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs200156181 | chr5:68306680-68306681 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs200441826 | chr5:68306792-68306793 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs397884015 | chr5:68306793-68306794 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs551729504 | chr5:68306806-68306807 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs569748791 | chr5:68306807-68306808 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs530828678 | chr5:68306852-68306853 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs369318024 | chr5:68306867-68306868 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs186880326 | chr5:68306884-68306885 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs568023641 | chr5:68306888-68306889 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs535631058 | chr5:68306899-68306900 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs553732171 | chr5:68306902-68306903 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs529112330 | chr5:68306946-68306947 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs191730071 | chr5:68306968-68306969 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs539195278 | chr5:68306970-68306971 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs557906021 | chr5:68307070-68307071 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs576082720 | chr5:68307075-68307076 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs542700921 | chr5:68307103-68307104 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs560991263 | chr5:68307124-68307125 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs373083763 | chr5:68307163-68307164 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 22032731 | CNVD |
Prostate cancer | 21965145 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Oral cancer | 21386901 | CNVD |
Bladder cancer | 21909424 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 19602461 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
abnormal development | 18461090 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Breast cancer | 21045282 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Lung cancer | 17086460 | CNVD |
Prostate cancer | 16461572 | CNVD |
Myelodysplastic syndrome | 18663149 | CNVD |
Spinal muscular atrophy | 15981080 | CNVD |
Spinal muscular atrophy | 18839960 | CNVD |
Spinal muscular atrophy | 19716110 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:68306000-68307000 | Weak transcription | Pancreas | Pancrea |
2 | chr5:68307000-68307400 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
3 | chr5:68307000-68308000 | Enhancers | Pancreas | Pancrea |
4 | chr5:68307400-68307600 | Bivalent Enhancer | Foreskin Fibroblast Primary Cells skin02 | Skin |
5 | chr5:68307800-68308200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
6 | chr5:68307800-68308200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
7 | chr5:68309200-68309600 | Enhancers | Fetal Kidney | kidney |
8 | chr5:68314800-68315600 | Enhancers | Primary T cells from cord blood | blood |
9 | chr5:68315400-68316200 | Enhancers | Fetal Brain Female | brain |
10 | chr5:68315800-68316000 | Bivalent Enhancer | NHDF-Ad | bronchial |
11 | chr5:68316200-68316600 | Enhancers | Fetal Brain Male | brain |
12 | chr5:68318000-68318400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
13 | chr5:68318200-68318800 | Enhancers | HSMMtube | muscle |
14 | chr5:68318400-68320200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
15 | chr5:68320200-68320400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
16 | chr5:68320200-68320800 | Enhancers | K562 | blood |
17 | chr5:68320400-68327000 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |